Alivus Life Sciences Ltd.

932.7

44.5 (5%)growUp

As on January 28, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap11,476 Cr
P/E Ratio23.53
Dividend Yield0.27 %
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open886
High937
NSE SymbolALIVUS
Close932.7
Low880.65
BSE Symbol543322
Previous Years High/Low
1 Year High1,251
3 Year High1,335.1
5 Year High1,335.1
1 Year Low819
3 Year Low370
5 Year Low370

Technicals


IndicatorsValueSignal
5-DMA885.44Bullish
10-DMA880.98Bullish
20-DMA892.25Bullish
50-DMA895.85Bullish
100-DMA914.03Bullish
200-DMA970.82Bearish

Historical Performance


1 Year
-19.1%
3 Years
139.8%
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:33.8
TTM:-19.4
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 23.53, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a strong 3-year price CAGR of 34.2%, indicating sustained price appreciation.
  • The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹7172 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹23869 million, indicating a large and established business.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 806485.1
No. of Shares: 865 (Approx)
Performance:-19.4%
P/L: ₹-193514.9
NIFTY Performance: 9.4%
1 day Top Gainers
SymbolChange%
TEJASNET339.05(15%)
DATAPATTNS2610.6(14%)
HINDCOPPER633.4(13%)
OLECTRA1088.4(10%)
SCHNEIDER697.7(10%)
1 Day Top Losers
SymbolChange%
RADICO2746.8(-6%)
HOMEFIRST1190.9(-5%)
TATACONSUM1131.8(-5%)
ASIANPAINT2511.8(-4%)
VMM119.86(-4%)
BERGEPAINT478.85(-3%)
EMCURE1435.8(-3%)
AIIL502.1(-3%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

68.6%

40.1

1 Month Performance

NGL Fine-Chem Ltd.

29.3%

1710.5

1 Month Performance

Ind-Swift Laboratories Ltd.

18.8%

108.7

1 Month Performance

Acutaas Chemicals Ltd.

12.7%

1862.4

1 Month Performance

Zim Laboratories Ltd.

9%

74.77

1 Month Performance

Torrent Pharmaceuticals Ltd.

3.7%

3958.7

1 Month Performance

Alkem Laboratories Ltd.

3.4%

5722.5

1 Month Performance

Aarti Pharmalabs Ltd.

2.7%

762.55

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month